UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000041873
Receipt No. R000047799
Scientific Title Effect of Neuromuscular Reversal by Sugammadex or Pyridostigmine on Post-anesthesia care unit Delirium and Postoperative Delirium after Lower Extremity Surgery under General Anesthesia in Elderly Patients: A Retrospective Cohort Study
Date of disclosure of the study information 2020/09/23
Last modified on 2022/07/08 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of Neuromuscular Reversal by Sugammadex or Pyridostigmine on Post-anesthesia care unit Delirium and Postoperative Delirium after Lower Extremity Surgery under General Anesthesia in Elderly Patients: A Retrospective Cohort Study
Acronym Suganmmadex versus pyridostygmin on Postoperative Delirium after lower extremity Surgery under General Anesthesia
Scientific Title Effect of Neuromuscular Reversal by Sugammadex or Pyridostigmine on Post-anesthesia care unit Delirium and Postoperative Delirium after Lower Extremity Surgery under General Anesthesia in Elderly Patients: A Retrospective Cohort Study
Scientific Title:Acronym Suganmmadex versus pyridostygmin on Postoperative Delirium after lower extremity Surgery under General Anesthesia
Region
Asia(except Japan)

Condition
Condition Elderly patients underwent lower extremity surgery under general anesthesia
Classification by specialty
Surgery in general Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This retrospective study aimed to investigate the effect of Suganmmadex versus pyridostygmin (anticholinerase inhibitor) on Post-anesthetic care unit Delirium and Postoperative Delirium in Elderly Patients underwent lower extremity surgery under general anesthesia
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The incidence of Post-anesthetic care unit Delirium assessed by CAM-ICU
Key secondary outcomes The incidence of Postoperative 5 day Delirium assessed by CAM-ICU

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Elderly Patients underwent Lower Extremity Surgery under General Anesthesia
Key exclusion criteria 1) ASA class >3 , 2) under 65 years old, 3) patients with neurological symptoms before surgery (dementia, Parkinson's disease, etc.), 4) patients with hearing and visual impairment, 5) possibility of illiteracy, 6) patients with mental illness, 7) patients who did not undergo neuromuscular reversal
Target sample size 160

Research contact person
Name of lead principal investigator
1st name Young Ju
Middle name
Last name Won
Organization Korea University Guro Hospital
Division name Seoul
Zip code 08308
Address 148, Gurodong-ro, Guro-gu, Seoul
TEL 82-2-2626-1437
Email moma2@naver.com

Public contact
Name of contact person
1st name Seok Kyeong
Middle name
Last name Oh
Organization Korea University Guro Hospital
Division name Seoul
Zip code 08308
Address 148, Gurodong-ro, Guro-gu, Seoul
TEL 82-2-2626-1437
Homepage URL
Email nanprayboy@korea.ac.kr

Sponsor
Institute Department of Anesthesiology and Pain Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Korea University Guro Hospital
Address 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea
Tel +82 2 2626 1635
Email ssessong@korea.ac.kr

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 09 Month 23 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 236
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 03 Month 26 Day
Date of IRB
2020 Year 03 Month 26 Day
Anticipated trial start date
2020 Year 04 Month 01 Day
Last follow-up date
2022 Year 07 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This is a retrospective observational study using datasets collected from medical records and clinical database.

Management information
Registered date
2020 Year 09 Month 23 Day
Last modified on
2022 Year 07 Month 08 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000047799